Genes and viruses in hepatobiliary neoplasia

Seminars in Surgical Oncology

Volumn 19, Issue 2, 2000, Pages 84-93

  Koea, Jonathan B ^a   Kemeny, Nancy ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Aflatoxin B1; APC genes; Cholangiocarcinoma; Codon; erbB 2 genes; Fos genes; Gallbladder neoplasms; Hepadnaviridae; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Liver cirrhosis; Liver neoplasms; Loss of heterozygosity p16 genes; Mutation; Myc genes; Oncogenes; p53 genes; Proto oncogenes; Ras genes; Retinoblastoma genes; Transcription; Tumor suppressor genes

Indexed keywords

AFLATOXIN B; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P16; PROTEIN P53; RAS PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; BILIARY TRACT CANCER; EARLY DIAGNOSIS; GENE MUTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; GENES, P53; GENES, RAS; GENES, TUMOR SUPPRESSOR; HEPATITIS B; HEPATITIS C; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; ONCOGENES;

EID: 0033773494     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2388(200009)19:2<84::AID-SSU2>3.0.CO;2-0     Document Type: Article

References (119)

1. Mutation and cancer: Statistical study of retinoblastoma
2. A genetic model for colorectal tumorigenesis
3. Genetic alterations during colorectal-tumor development
4. Oncogenic forms of p53 inhibit p53-regulated gene expression
5. Identification of FAP locus genes from chromosome 5q21
6. Beta-catenin as oncogene: The smoking gun
7. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age
8. Expression of recessive alleles; by chromosomal mechanisms in retinoblastoma
9. Function and regulation of ras
10. The biology of erbB-2/neu/HER-2 and its role in cancer
11. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product
12. The myc oncogene: Its role in transformation and differentiation
13. Dangerous liaisons: Fos, jun, oncogenic transcription factors
14. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
15. Genetic heterogeneity of hepatocellular carcinoma
16. Rising incidence of hepatocellular carcinoma in the United States
17. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice
18. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma
19. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis
20. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
21. p53 gene mutation spectrum in hepatocellular carcinoma
22. Mutational properties of the primary aflatoxin B1-DNA adduct
23. Aflatoxins as risk factors for hepatocellular carcinoma in humans
24. p53 mutation in hepatocellular carcinoma after aflatoxin exposure
25. Genetic aspects of hepatocellular carcinogenesis
26. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
27. Aberrations of p53 gene in human hepatocellular carcinoma from China
28. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China
29. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal
30. Mutation at codon 249 of p53 gene in a human hepatoblastoma
31. p53 abnormalities in hepatocellular carcinoma from United States patients: Analysis of all 11 exons
32. Functional inactivation but not structural mutation of p53 causes liver cancer
33. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma
34. Mutation of p53 gene in hepatocellular carcinoma in Taiwan
35. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
36. Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates
37. Geographic variation of p53 mutational profile in nonmalignant human liver
38. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
39. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
40. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
41. Molecular mechanisms of hepatocarcinogenesis
42. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma
43. Deletions and rearrangements of the retinoblastoma gene in hepatocellular carcinoma, insulinoma and some neurogenic tumors as found in a study of 121 tumors
44. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma
45. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma
46. Germ-line mutations of the p161NK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma
47. Inactivation of p16INK4 in hepatocellular carcinoma
48. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma
49. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma
50. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction
51. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing
52. A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis
53. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma
54. c-met mRNA overexpression in human hepatocellular carcinoma
55. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma
56. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan
57. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma
58. Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma
59. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis
60. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
61. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: A comparative study of histopathology and frequency of hepatitis B markers
62. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA
63. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX
64. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
65. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
66. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liven
67. Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product
68. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
69. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
70. State of hepatitis B viral genomes in cirrhotic and hepatocellular carcinoma nodules
71. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
72. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma
73. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma
74. Molecular events in the pathogenesis of hepadna-virus-associated hepatocellular carcinoma
75. Integration of hepatitis B virus sequences and their expression in a human hepatoma cell
76. Frequent activation of N- myc genes by hepadnavirus insertion in woodchuck liver tumours
77. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma
78. Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus
79. Hepatitis C virus: Epidemiology and transmission
80. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan
81. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis
82. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study
83. HCV-associated liver cancer without cirrhosis
84. Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous human antibodies
85. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: A study by in situ reverse-transcription polymerase chain reaction
86. Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma
87. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HUH-7 cells
88. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein
89. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
90. Suppression of apoptotic cell death by hepatitis C virus core protein
91. Transcriptional repression of p53 promoter by hepatitis C virus core protein
92. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
93. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency
94. Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: Interaction of inherited susceptibility and hepatitis B viral infection
95. Clustering of hepatocellular carcinoma in Alaska Native families
96. Mutations of the p53 tremor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand
97. Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: Relation to gross tumor morphology
98. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma
99. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma
100. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas
101. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers
102. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
103. Oncogene expression in cholangiocarcinoma and in normal hepatic development
104. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
105. Point mutation of K-ras gene codon 12 in biliary tract tumors
106. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis
107. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas
108. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique
109. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections
110. Differences in c-fos gene product expression in cancers of the gall-bladder and biliary tract
111. Mutation of the p53 gene in gallbladder cancer
112. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile
113. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder
114. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary malfunction
115. Detection of ras oncogene point mutations and simultaneous proliferative fraction estimation in gallbladder cancer
116. K-ras gene mutation in gall bladder carcinomas and dysplasia
117. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union
118. An inununohistochemical and molecular biological study of c-erbB-2 amplification and prognostic relevance in gallbladder cancer
119. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa